Biotrial and SGS Life Sciences Receive High Marks for Accessibility

Informing pharmaceutical drug developers, manufacturers, and service providers Raleigh, N.C. – September 27, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its CRO Quality Benchmarking – Phase I Service Providers series. ISR surveyed 305 decision-makers at sponsor organizations to gather their insights on topics such as service provider … Continued

CRO Growth Continues, ISR Projects More Growth to Come

Informing the drug development and pharmaceutical manufacturing industry. Raleigh, N.C. – September 25, 2018 – Industry Standard Research (ISR) has announced the newest edition of its CRO market analysis report “2018 CRO Market Size Projections: 2017-2022.” For this report, ISR has utilized publicly available information from biopharma, government, private, non-profit, and academic institutions as well as … Continued

Large CROs Stand Out in Post-marketing Pharmacovigilance

Informing pharmaceutical drug developers, manufacturers, and service providers. Raleigh, N.C. – September 24, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its CRO Quality Benchmarking – Phase IV Service Providers series. ISR surveyed 230 decision-makers at sponsor organizations to gather their insights on topics such as service provider brand perceptions and use, … Continued

Time To Silence Capacity Alarms For Bioprocessing?

Chief Editor Louis Garguilo at Outsourced Pharma speaks with VP of Industry Standard Research Kate Hammeke about the non-appearance of a long-anticipated capacity crunch for bioprocessing services. One thing is certain: When considering overall outsourcing capacity, there are mitigating factors at work in the marketplace. The most important is that the bigger drug sponsors have in … Continued

A Hypothetical Question About Outsourcing Services Leads To … More Questions?

VP of Market Research at Industry Standard Research Kate Hammeke reviews some interesting findings which arose from comparing a theoretical question’s responses to other survey results. The five most common answers to this unaided question offer no real surprises on their own: quality (49 percent), price/affordability (41 percent), timelines (32 percent), expertise (29 percent), and regulatory compliance … Continued

ISR CUSTOMERS